-
1
-
-
33747862996
-
The road map to oral bioavailability: An industrial perspective
-
Thomas, V.H.; Bhattachar, S.; Hitchingham, L.; Zocharski, P.; Naath, M.; Surendran, N.; Stoner, C.L.; El-Kattan, A. The road map to oral bioavailability: an industrial perspective. Expert. Opin. Drug Metab. Toxicol., 2006, 2 (4), 591-608.
-
(2006)
Expert. Opin. Drug Metab. Toxicol
, vol.2
, Issue.4
, pp. 591-608
-
-
Thomas, V.H.1
Bhattachar, S.2
Hitchingham, L.3
Zocharski, P.4
Naath, M.5
Surendran, N.6
Stoner, C.L.7
El-Kattan, A.8
-
2
-
-
34547864243
-
Drug delivery strategies for poorly water-soluble drugs
-
Fahr, A.; Liu, X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug Deliv., 2007, 4 (4), 403-416.
-
(2007)
Expert Opin. Drug Deliv
, vol.4
, Issue.4
, pp. 403-416
-
-
Fahr, A.1
Liu, X.2
-
3
-
-
0027686733
-
Mechanisms, barriers and pathways of oral mucosal drug permeation
-
Rathbone, M.J.; Tucker, I.G. Mechanisms, barriers and pathways of oral mucosal drug permeation. Adv. Drug Deliv. Rev., 1993, 12, 41-60.
-
(1993)
Adv. Drug Deliv. Rev
, vol.12
, pp. 41-60
-
-
Rathbone, M.J.1
Tucker, I.G.2
-
4
-
-
0034002854
-
Virtual screening of intestinal drug permeability
-
Stenberg, P.; Luthman, K.; Artursson, P. Virtual screening of intestinal drug permeability. J. Control. Release., 2000, 65, 231-243.
-
(2000)
J. Control. Release
, vol.65
, pp. 231-243
-
-
Stenberg, P.1
Luthman, K.2
Artursson, P.3
-
5
-
-
0032872193
-
Paracellular drug transport across epithelia: Influence of charge and induced water flux
-
Karlsson, J.; Ungell, A.; Grasjo, J.; Artursson, P. Paracellular drug transport across epithelia: influence of charge and induced water flux. Eur. J. Pharm. Sci., 1999, 9, 47-56.
-
(1999)
Eur. J. Pharm. Sci
, vol.9
, pp. 47-56
-
-
Karlsson, J.1
Ungell, A.2
Grasjo, J.3
Artursson, P.4
-
6
-
-
0027312774
-
Selective paracellular permeability in two models of intestinal absorption: Cultured monolayers of human intestinal epithelial cells and rat intestinal segments
-
Artursson, P.; Ungell, A.; Lofroth, J.E. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res., 1993, 10, 1123-1129.
-
(1993)
Pharm. Res
, vol.10
, pp. 1123-1129
-
-
Artursson, P.1
Ungell, A.2
Lofroth, J.E.3
-
7
-
-
0032403463
-
The effect of physical barriers and properties on the oral absorption of particulates
-
Norris, D.A.; Puri, N.; Sinko, P.J. The effect of physical barriers and properties on the oral absorption of particulates. Adv. Drug Deliv. Rev., 1998, 34, 135-154.
-
(1998)
Adv. Drug Deliv. Rev
, vol.34
, pp. 135-154
-
-
Norris, D.A.1
Puri, N.2
Sinko, P.J.3
-
8
-
-
0347824359
-
A new principle for tight junction modulation based on occludin peptides
-
Tavelin, S.; Hasimoto, K.; Malkinson, J.; Lazarova, L.; Toth, I.; Artursson, P. A new principle for tight junction modulation based on occludin peptides. Mol. Pharmacol., 2003, 64 (6), 1530-1540.
-
(2003)
Mol. Pharmacol
, vol.64
, Issue.6
, pp. 1530-1540
-
-
Tavelin, S.1
Hasimoto, K.2
Malkinson, J.3
Lazarova, L.4
Toth, I.5
Artursson, P.6
-
9
-
-
17844406157
-
Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery
-
Cano-Cebrian, M.J.; Zornoza, T.; Granero, L.; Polache, A. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: A target for drug delivery. Curr. Drug. Deliv., 2005, 2, 9-22.
-
(2005)
Curr. Drug. Deliv
, vol.2
, pp. 9-22
-
-
Cano-Cebrian, M.J.1
Zornoza, T.2
Granero, L.3
Polache, A.4
-
10
-
-
0032862501
-
Structure and function of tight junctions. Role in intestinal barrier
-
Gasbarrini, G.; Montalto, M. Structure and function of tight junctions. Role in intestinal barrier. Ital. J. Gastroenterol. Hepatol. 1999, 31 (6): 481-488.
-
(1999)
Ital. J. Gastroenterol. Hepatol
, vol.31
, Issue.6
, pp. 481-488
-
-
Gasbarrini, G.1
Montalto, M.2
-
11
-
-
80054066195
-
-
Harwood Academic Publishers: Churchil livingstone
-
Noach, A.; Hurni, M.A.; De Boer, A.G.; Breimer, D.D. Drug Absorption Enhancement. Concept, Possibilities, Limitations and Trends. Harwood Academic Publishers: Churchil livingstone, 1994.
-
(1994)
Drug Absorption Enhancement. Concept, Possibilities, Limitations and Trends
-
-
Noach, A.1
Hurni, M.A.2
de Boer, A.G.3
Breimer, D.D.4
-
12
-
-
0023612699
-
Structure, biochemistry, and assembly of epithelial tight junctions
-
Gumbiner, B. Structure, biochemistry, and assembly of epithelial tight junctions. Am. J. Physiol., 1987, 253, C749-C758.
-
(1987)
Am. J. Physiol
, vol.253
-
-
Gumbiner, B.1
-
13
-
-
0033825953
-
Molecular physiology and pathophysiology of tight junctions I. Biogenesis of tight junctions and epithelial polarity
-
Cereijido, L.; Shoshani, L.; Contreras, R.G. Molecular physiology and pathophysiology of tight junctions I. Biogenesis of tight junctions and epithelial polarity. Am J. Physiol. Gastrointest. Liver Physiol., 2000, 279, G477-G482.
-
(2000)
Am J. Physiol. Gastrointest. Liver Physiol
, vol.279
-
-
Cereijido, L.1
Shoshani, L.2
Contreras, R.G.3
-
14
-
-
0029912970
-
Interspecies diversity of the occludin sequence: CDNA cloning of human, mouse, dog, and rat-kangaroo homologues
-
Ando-Akatsuka, Y.; Saitou, M.; Hirase, T.; Kishi, M.; Sakakibara, A.; Itoh, M.; Yonemura, S.; Furuse, M.; Tsukita, S. J. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J. Cell. Biol. 1996, 133, 43-47.
-
(1996)
J. Cell. Biol
, vol.133
, pp. 43-47
-
-
Ando-Akatsuka, Y.1
Saitou, M.2
Hirase, T.3
Kishi, M.4
Sakakibara, A.5
Itoh, M.6
Yonemura, S.7
Furuse, M.8
Tsukita, S.J.9
-
15
-
-
0030811141
-
Mammalian occludin in epithelial cells: Its expression and subcellular distribution
-
Saitou, M.; Ando-Akatsuka, Y.; Itoh, M.; Furuse, M.; Inazawa, J.; Fujimoto, K.; Tsukita, S. Mammalian occludin in epithelial cells: its expression and subcellular distribution. Eur. J. Cell. Biol., 1997, 73, 222-231.
-
(1997)
Eur. J. Cell. Biol
, vol.73
, pp. 222-231
-
-
Saitou, M.1
Ando-Akatsuka, Y.2
Itoh, M.3
Furuse, M.4
Inazawa, J.5
Fujimoto, K.6
Tsukita, S.7
-
16
-
-
0033516683
-
+ resorption
-
+ resorption. Science, 1999, 285, 103-106.
-
(1999)
Science
, vol.285
, pp. 103-106
-
-
Simon, D.B.1
Lu, Y.2
Choate, K.A.3
Velazquez, H.4
Al-Sabban, E.5
Praga, M.6
Casari, G.7
Bettinelli, A.8
Colussi, G.9
Rodríguez, S.J.10
McCredie, D.11
Milford, D.12
Sanjad, S.13
Lifton, R.P.14
-
17
-
-
0027842835
-
Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals
-
Borst, P.; Schinkel, A.H.; Smit, J.J.; Wagenaar, E.; Van Deemter, L.; Smith, A.J.; Eijdems, E.W.; Baas, F.; Zaman, G.J. Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol. Ther., 1993, 60, 289-299.
-
(1993)
Pharmacol. Ther
, vol.60
, pp. 289-299
-
-
Borst, P.1
Schinkel, A.H.2
Smit, J.J.3
Wagenaar, E.4
van Deemter, L.5
Smith, A.J.6
Eijdems, E.W.7
Baas, F.8
Zaman, G.J.9
-
18
-
-
84862752965
-
Solvo in vitro transporter assay technology
-
Solvo biotechnology. Available at, Last accessed 4 October
-
Solvo in vitro transporter assay technology. Solvo biotechnology. Available at: www.solvo.com. [Last accessed 4 October 2010].
-
(2010)
-
-
-
19
-
-
0035290059
-
Active secretion and enterocytic drug metabolism barriers to drug absorption
-
Wacher, V.J.; Salphati, L.; Benet, L.Z. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev., 2001, 46 (1-3), 89-102.
-
(2001)
Adv. Drug Deliv. Rev
, vol.46
, Issue.1-3
, pp. 89-102
-
-
Wacher, V.J.1
Salphati, L.2
Benet, L.Z.3
-
20
-
-
0035054725
-
The gut as a barrier to drug absorption: Combined role of cytochrome P450 3A and P-glycoprotein
-
Zhang, Y.; Benet, L.Z. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin. Pharmacokinet., 2001, 40 (3), 159-168.
-
(2001)
Clin. Pharmacokinet
, vol.40
, Issue.3
, pp. 159-168
-
-
Zhang, Y.1
Benet, L.Z.2
-
21
-
-
9444267085
-
Functional interaction of intestinal CYP3A4 and P-glycoprotein
-
Kivisto, K.T.; Niemi, M.; Fromm, M.F. Functional interaction of intestinal CYP3A4 and P-glycoprotein. Fundam. Clin. Pharmacol., 2004, 18 (6), 621-626.
-
(2004)
Fundam. Clin. Pharmacol
, vol.18
, Issue.6
, pp. 621-626
-
-
Kivisto, K.T.1
Niemi, M.2
Fromm, M.F.3
-
22
-
-
0030581087
-
Active secretion and enterocytic drug metabolism barriers to drug absorption
-
Wacher, V.J.; Salphati, L.; Benet, L.Z. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev., 1996, 20, 99-112.
-
(1996)
Adv. Drug Deliv. Rev
, vol.20
, pp. 99-112
-
-
Wacher, V.J.1
Salphati, L.2
Benet, L.Z.3
-
23
-
-
0034461768
-
Drug-like properties and the causes of poor solubility and poor permeability
-
Lipinski, C.A. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Meth., 2000, 44 (1), 235-249.
-
(2000)
J. Pharmacol. Toxicol. Meth
, vol.44
, Issue.1
, pp. 235-249
-
-
Lipinski, C.A.1
-
24
-
-
34447536520
-
When poor solubility becomes an issue: From early stage to proof of concept
-
Stegemann, S.; Leveiller, F.; Franchi, D.; de Jong, H. When poor solubility becomes an issue: From early stage to proof of concept. Eur. J. Pharm. Sci., 2007, 31, 249-261.
-
(2007)
Eur. J. Pharm. Sci
, vol.31
, pp. 249-261
-
-
Stegemann, S.1
Leveiller, F.2
Franchi, D.3
de Jong, H.4
-
25
-
-
0034713284
-
Biopharmaceutics and pharmacokinetics in drug research
-
Panchagnula, R.; and Thomas, N.S. Biopharmaceutics and pharmacokinetics in drug research. Int. J. Pharm., 2000, 201, 131-150.
-
(2000)
Int. J. Pharm
, vol.201
, pp. 131-150
-
-
Panchagnula, R.1
Thomas, N.S.2
-
26
-
-
34548049221
-
Oral lipid-based formulations
-
Hauss, D.J. Oral lipid-based formulations. Adv. Drug Deliv. Rev., 2007, 59, 667-676.
-
(2007)
Adv. Drug Deliv. Rev
, vol.59
, pp. 667-676
-
-
Hauss, D.J.1
-
27
-
-
68349160715
-
Lipid-An emerging platform for oral delivery of drugs with poor bioavailability
-
Chakraborty, S.; Shukla, D.; Mishra B, Singh S. Lipid-An emerging platform for oral delivery of drugs with poor bioavailability. Eur. J. Pharm. Biopharm., 2009, 73 (1), 1-15.
-
(2009)
Eur. J. Pharm. Biopharm
, vol.73
, Issue.1
, pp. 1-15
-
-
Chakraborty, S.1
Shukla, D.2
Mishra, B.3
Singh, S.4
-
28
-
-
0031914282
-
Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly watersoluble LTB4 inhibitor
-
Hauss, D.J.; Fogal, S.E.; Ficorilli, J.V.; Price, C.A.; Roy, T.; Jayaraj, A.A.; Keirns, J.J. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly watersoluble LTB4 inhibitor. J. Pharm. Sci., 1998, 87, 164-169.
-
(1998)
J. Pharm. Sci
, vol.87
, pp. 164-169
-
-
Hauss, D.J.1
Fogal, S.E.2
Ficorilli, J.V.3
Price, C.A.4
Roy, T.5
Jayaraj, A.A.6
Keirns, J.J.7
-
29
-
-
0033818432
-
Effect of short, medium and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and noncannulated rats
-
Caliph, S.M.; Charman, W.N.; Porter, C.J. Effect of short, medium and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and noncannulated rats. J. Pharm. Sci., 2000, 89, 1073-1084.
-
(2000)
J. Pharm. Sci
, vol.89
, pp. 1073-1084
-
-
Caliph, S.M.1
Charman, W.N.2
Porter, C.J.3
-
30
-
-
0029562489
-
Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects
-
Constantinides, P.P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res., 1995, 12, 1561-1572.
-
(1995)
Pharm. Res
, vol.12
, pp. 1561-1572
-
-
Constantinides, P.P.1
-
31
-
-
55949089032
-
A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: Characterization, dissolution, in vitro digestion and incorporation into solid pellets
-
Abdalla, A.; Klein, S.; Mader, K. A new self-emulsifying drug delivery system (SEDDS) for poorly soluble drugs: Characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur. J. Pharm. Sci., 2008, 35 (5), 457-464.
-
(2008)
Eur. J. Pharm. Sci
, vol.35
, Issue.5
, pp. 457-464
-
-
Abdalla, A.1
Klein, S.2
Mader, K.3
-
32
-
-
45849115831
-
Development of solid selfemulsifying drug delivery systems: Preparation techniques and dosage forms
-
Tang, B.; Cheng, G.; Gu, J.C.; Xu, C.H. Development of solid selfemulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov. Today, 2008, 13 (13/14), 606-612.
-
(2008)
Drug Discov. Today
, vol.13
, Issue.13-14
, pp. 606-612
-
-
Tang, B.1
Cheng, G.2
Gu, J.C.3
Xu, C.H.4
-
33
-
-
78349310868
-
Selfemulsifying drug delivery systems: An approach to enhance oral bioavailability
-
Kohli, K.; Chopra, S.; Dhar, D.; Arora, S.; Khar, R.K. Selfemulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov. Today, 2010, 15 (21-22), 958-965.
-
(2010)
Drug Discov. Today
, vol.15
, Issue.21-22
, pp. 958-965
-
-
Kohli, K.1
Chopra, S.2
Dhar, D.3
Arora, S.4
Khar, R.K.5
-
34
-
-
10044223246
-
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
-
Hu, L.D.; Tang, X.; Cui, F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J. Pharm. Pharmacol., 2004, 56, 1527-1535.
-
(2004)
J. Pharm. Pharmacol
, vol.56
, pp. 1527-1535
-
-
Hu, L.D.1
Tang, X.2
Cui, F.3
-
35
-
-
0035667509
-
Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent
-
Gupta, M.K.; Goldman, D.; Bogner, R.H.; Tseng, Y.C. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm. Dev. Technol., 2001, 6, 563-572.
-
(2001)
Pharm. Dev. Technol
, vol.6
, pp. 563-572
-
-
Gupta, M.K.1
Goldman, D.2
Bogner, R.H.3
Tseng, Y.C.4
-
36
-
-
0038032150
-
Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art
-
Muller, R.H.; Mader, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm., 2000, 50, 161-177.
-
(2000)
Eur. J. Pharm. Biopharm
, vol.50
, pp. 161-177
-
-
Muller, R.H.1
Mader, K.2
Gohla, S.3
-
37
-
-
20444508016
-
Oral solid gentamicin preparation using emulsifier and adsorbent
-
Ito, Y.; Kusawake, T.; Ishida, M.; Tawa, R.; Shibata, N.; Takada, K. Oral solid gentamicin preparation using emulsifier and adsorbent. J. Control. Release, 2005, 105, 23-31.
-
(2005)
J. Control. Release
, vol.105
, pp. 23-31
-
-
Ito, Y.1
Kusawake, T.2
Ishida, M.3
Tawa, R.4
Shibata, N.5
Takada, K.6
-
38
-
-
0035946615
-
Solid lipid nanoparticles: Production characterization and applications
-
Mehnert, W.; Mader, K. Solid lipid nanoparticles: production characterization and applications. Adv. Drug Del. Rev., 2001, 47, 165-196.
-
(2001)
Adv. Drug Del. Rev
, vol.47
, pp. 165-196
-
-
Mehnert, W.1
Mader, K.2
-
39
-
-
39149113817
-
Formulation of lipid-based delivery systems for oral administration: Materials methods and strategies
-
Pouton, C.W.; Porter, C.J.H. Formulation of lipid-based delivery systems for oral administration: materials methods and strategies. Adv. Drug Del. Rev., 2008, 60, 625-637.
-
(2008)
Adv. Drug Del. Rev
, vol.60
, pp. 625-637
-
-
Pouton, C.W.1
Porter, C.J.H.2
-
40
-
-
1242292226
-
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations
-
Kaukonen, A.M.; Boyd, B.J.; Porter, C.J.H.; Charman, W.N. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm. Res., 2004, 21, 245-253.
-
(2004)
Pharm. Res
, vol.21
, pp. 245-253
-
-
Kaukonen, A.M.1
Boyd, B.J.2
Porter, C.J.H.3
Charman, W.N.4
-
41
-
-
67249086096
-
Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs
-
Simovic, S.; Heard, P.; Hui, H.; Song, Y.; Peddie, F.; Davey, A.K.; Lewis, A.; Rades, T.; Prestidge, C.A. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Mol. Pharm., 2009, 6 (3), 861-872.
-
(2009)
Mol. Pharm
, vol.6
, Issue.3
, pp. 861-872
-
-
Simovic, S.1
Heard, P.2
Hui, H.3
Song, Y.4
Peddie, F.5
Davey, A.K.6
Lewis, A.7
Rades, T.8
Prestidge, C.A.9
-
42
-
-
77950591046
-
Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems
-
Tan, A.; Simovic, S.; Davey, A.K.; Rades, T.; Boyd, B.J.; Prestidge, C.A. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Mol. Pharm., 2010, 7 (2), 522-532.
-
(2010)
Mol. Pharm
, vol.7
, Issue.2
, pp. 522-532
-
-
Tan, A.1
Simovic, S.2
Davey, A.K.3
Rades, T.4
Boyd, B.J.5
Prestidge, C.A.6
-
43
-
-
76249133449
-
Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs
-
Wang, F.; Hui, H.; Barnes, T.J.; Barnett, C.; Prestidge, C.A. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol. Pharm., 2010, 7 (1), 227-236.
-
(2010)
Mol. Pharm
, vol.7
, Issue.1
, pp. 227-236
-
-
Wang, F.1
Hui, H.2
Barnes, T.J.3
Barnett, C.4
Prestidge, C.A.5
-
44
-
-
67349097388
-
Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt
-
Chen Y.; Lu, Y.; Chen, J.; Lai, J.; Sun, J.; Hu, F.; Wu, W. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int. J. Pharm., 2009, 376 (1-2), 153-160.
-
(2009)
Int. J. Pharm
, vol.376
, Issue.1-2
, pp. 153-160
-
-
Chen, Y.1
Lu, Y.2
Chen, J.3
Lai, J.4
Sun, J.5
Hu, F.6
Wu, W.7
-
45
-
-
58949089131
-
Oral cyclosporine A-the current picture of its liposomal and other delivery systems
-
Czogalla, A. Oral cyclosporine A-the current picture of its liposomal and other delivery systems. Cell Mol. Biol. Lett., 2009, 14, 139-152.
-
(2009)
Cell Mol. Biol. Lett
, vol.14
, pp. 139-152
-
-
Czogalla, A.1
-
46
-
-
0029070813
-
Preparation and characterization of liposomes as therapeutic delivery systems: A review
-
Vemuri, S.; Rhodes, C.T. Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharm. Acta Helvetiae., 1995, 70, 95-111.
-
(1995)
Pharm. Acta Helvetiae
, vol.70
, pp. 95-111
-
-
Vemuri, S.1
Rhodes, C.T.2
-
47
-
-
69549112751
-
Proliposomes of exemestane for improved oral delivery: Formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine
-
Hiremath, P.S.; Soppimath, K.S.; Betageri, G.V. Proliposomes of exemestane for improved oral delivery: Formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine. Int. J. Pharm., 2009, 380 (1-2), 96-104.
-
(2009)
Int. J. Pharm
, vol.380
, Issue.1-2
, pp. 96-104
-
-
Hiremath, P.S.1
Soppimath, K.S.2
Betageri, G.V.3
-
48
-
-
0027185555
-
Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract
-
Arien, A.C.; Goigoux, C.; Dupuy, B.B. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract. Life Sci., 1993, 53, 1279-1290.
-
(1993)
Life Sci
, vol.53
, pp. 1279-1290
-
-
Arien, A.C.1
Goigoux, C.2
Dupuy, B.B.3
-
49
-
-
17644395023
-
Oral Delivery of Poorly Soluble Drugs: Part 1
-
Hite, M.; Turner, S.; Federici, C. Oral Delivery of Poorly Soluble Drugs: Part 1. PMPS Summer, 2003, 3, 38-40.
-
(2003)
PMPS Summer
, vol.3
, pp. 38-40
-
-
Hite, M.1
Turner, S.2
Federici, C.3
-
50
-
-
79957789430
-
Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs
-
Krishnaiah, Y.S.R. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J. Bioequival. Bioavail., 2010, 2 (2), 28-36.
-
(2010)
J. Bioequival. Bioavail
, vol.2
, Issue.2
, pp. 28-36
-
-
Krishnaiah, Y.S.R.1
-
52
-
-
78650006193
-
-
U.S. Patent 7,600,703
-
Greenwood AK, Mchattie D, Bhatarah P, Hembra G. Particle Size Reduction Apparatus and Use Thereof. U.S. Patent 7,600,703, 2009.
-
(2009)
Particle Size Reduction Apparatus and Use Thereof
-
-
Greenwood, A.K.1
McHattie, D.2
Bhatarah, P.3
Hembra, G.4
-
53
-
-
34548049483
-
Nanosizing-Oral formulation development and biopharmaceutical evaluation
-
Kesisoglou, F.; Panmai, S.; Wu, Y. Nanosizing-Oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev., 2007, 59, 631-644.
-
(2007)
Adv. Drug Deliv. Rev
, vol.59
, pp. 631-644
-
-
Kesisoglou, F.1
Panmai, S.2
Wu, Y.3
-
54
-
-
3042814562
-
Nanosuspensions: A promising drug delivery strategy
-
Patravale, V.B.; Date, A.A.; Kulkarni, R.M. Nanosuspensions: A promising drug delivery strategy. J. Pharm. Pharmacol., 2004, 56 (7), 827-840.
-
(2004)
J. Pharm. Pharmacol
, vol.56
, Issue.7
, pp. 827-840
-
-
Patravale, V.B.1
Date, A.A.2
Kulkarni, R.M.3
-
55
-
-
0035937599
-
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future
-
Muller, R.H.; Jacobs, C.; Kayser, O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev., 2001, 47, 3-19.
-
(2001)
Adv. Drug Deliv. Rev
, vol.47
, pp. 3-19
-
-
Muller, R.H.1
Jacobs, C.2
Kayser, O.3
-
56
-
-
38349134916
-
Dendrimers as drug carriers: Applications in different routes of drug administration
-
Cheng, Y.; Xu, Z.; Ma, M.; Xu, T. Dendrimers as drug carriers: applications in different routes of drug administration. J. Pharm. Sci., 2008, 97 (1), 123-143
-
(2008)
J. Pharm. Sci
, vol.97
, Issue.1
, pp. 123-143
-
-
Cheng, Y.1
Xu, Z.2
Ma, M.3
Xu, T.4
-
57
-
-
0033061971
-
Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration
-
Sakthivel, T.; Toth, I.; Florence, A.T. Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration. Int. J. Pharm., 1999, 183 (1), 51-55.
-
(1999)
Int. J. Pharm
, vol.183
, Issue.1
, pp. 51-55
-
-
Sakthivel, T.1
Toth, I.2
Florence, A.T.3
-
58
-
-
0034000927
-
Oral uptake and translocation of a polylysine dendrimer with a lipid surface
-
Florence A.T.; Sakthivel, T.; Toth, I. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J. Control. Release, 2000, 65, 253-259.
-
(2000)
J. Control. Release
, vol.65
, pp. 253-259
-
-
Florence, A.T.1
Sakthivel, T.2
Toth, I.3
-
59
-
-
0028048082
-
Bidirectional small-intestinal permeability in the rat to some common marker molecules in-vitro
-
Pantzar, N.; Lundin, S.; Wester, L.; Westrom, B.R. Bidirectional small-intestinal permeability in the rat to some common marker molecules in-vitro. Scand. J. Gastroenterol., 1994, 29, 703-709.
-
(1994)
Scand. J. Gastroenterol
, vol.29
, pp. 703-709
-
-
Pantzar, N.1
Lundin, S.2
Wester, L.3
Westrom, B.R.4
-
60
-
-
1542509564
-
The use of a dendrimer-Propranolol prodrug to bypass efflux transporters and enhance oral bioavailability
-
D'Emanuele, A.; Jevprasesphant, R.; Penny, J.; Attwood, D. The use of a dendrimer-Propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J. Control. Release, 2004, 95, 447-453.
-
(2004)
J. Control. Release
, vol.95
, pp. 447-453
-
-
D'Emanuele, A.1
Jevprasesphant, R.2
Penny, J.3
Attwood, D.4
-
61
-
-
0036218793
-
Dendrimer grafts for delivery of 5-fluorouracil
-
Tripathi, P.K.; Khopade, A.J.; Nagaich, S.; Shrivastava, S.; Jain, S.; Jain, N.K. Dendrimer grafts for delivery of 5-fluorouracil. Pharmazie, 2002, 57, 261-264.
-
(2002)
Pharmazie
, vol.57
, pp. 261-264
-
-
Tripathi, P.K.1
Khopade, A.J.2
Nagaich, S.3
Shrivastava, S.4
Jain, S.5
Jain, N.K.6
-
62
-
-
33646778115
-
Dendrimers as potential drug carriers. Part II. Prolonged delivery of Ketoprofen by in vitro and in vivo studies
-
Man, N.; Cheng, Y.Y.; Xu, T.W.; Yang, D.; Xiaomin, W.; Zhenwei, L.; Zhichao, C.; Guanyi, H.; Yunyu, S.; Longping, W. Dendrimers as potential drug carriers. Part II. Prolonged delivery of Ketoprofen by in vitro and in vivo studies. Eur. J. Med. Chem., 2006, 41, 670-674.
-
(2006)
Eur. J. Med. Chem
, vol.41
, pp. 670-674
-
-
Man, N.1
Cheng, Y.Y.2
Xu, T.W.3
Yang, D.4
Xiaomin, W.5
Zhenwei, L.6
Zhichao, C.7
Guanyi, H.8
Yunyu, S.9
Longping, W.10
-
63
-
-
1542378832
-
Overcoming the insolubility of carbon nanotubes through high degrees of sidewall functionalization
-
Dyke, C.A.; Tour, J.M. Overcoming the insolubility of carbon nanotubes through high degrees of sidewall functionalization. Chem. Eur. J., 2004, 10 (4), 812-817.
-
(2004)
Chem. Eur. J
, vol.10
, Issue.4
, pp. 812-817
-
-
Dyke, C.A.1
Tour, J.M.2
-
64
-
-
0141761403
-
Soluble carbon nanotubes
-
Tasis, D.; Tagmatarchis, N.; Georgakilas, V.; Prato, M. Soluble carbon nanotubes. Chem. Eur. J., 2003, 9, 4000-4008.
-
(2003)
Chem. Eur. J
, vol.9
, pp. 4000-4008
-
-
Tasis, D.1
Tagmatarchis, N.2
Georgakilas, V.3
Prato, M.4
-
65
-
-
65649083431
-
Re-sensitive and highly water-soluble titanate nanotubes
-
Gao, Y.; Zhou, Y.; Yan, D. Re-sensitive and highly water-soluble titanate nanotubes. Polymer, 2009, 50, 2572-2577.
-
(2009)
Polymer
, vol.50
, pp. 2572-2577
-
-
Gao, Y.1
Zhou, Y.2
Yan, D.3
-
66
-
-
78751514108
-
Advancement in carbon nanotubes: Basics, biomedical applications and toxicity
-
Beg, S.; Rizwan, M.; Sheikh, AM.; Hasnain, M.S.; Anwer, K.; Kohli, K. Advancement in carbon nanotubes: basics, biomedical applications and toxicity. J. Pharm. Pharmacol., 2011, 63, 141-163.
-
(2011)
J. Pharm. Pharmacol
, vol.63
, pp. 141-163
-
-
Beg, S.1
Rizwan, M.2
Sheikh, A.M.3
Hasnain, M.S.4
Anwer, K.5
Kohli, K.6
-
67
-
-
0141732678
-
Cyclodextrins and carrier systems
-
Duchene, D.; Wouessidjewe, D.; Ponchel, G. Cyclodextrins and carrier systems. J. Control. Release, 1999, 62, 263-268.
-
(1999)
J. Control. Release
, vol.62
, pp. 263-268
-
-
Duchene, D.1
Wouessidjewe, D.2
Ponchel, G.3
-
68
-
-
34548134519
-
Cyclodextrins as pharmaceutical solubilizers
-
Brewster, M.E.; Loftsson, T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev., 2007, 59, 645-666.
-
(2007)
Adv. Drug Deliv. Rev
, vol.59
, pp. 645-666
-
-
Brewster, M.E.1
Loftsson, T.2
-
69
-
-
34547864243
-
Drug delivery strategies for poorly water-soluble drugs
-
Fahr, A.; Liu, X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug Deliv., 2007, 4, 403-416.
-
(2007)
Expert Opin. Drug Deliv
, vol.4
, pp. 403-416
-
-
Fahr, A.1
Liu, X.2
-
70
-
-
31144433828
-
Formulation and biological evaluation of glimepiride-cyclodextrinpolymer systems
-
Ammar, H.O.; Salama, H.A.; Ghorab, M.; Mahmoud, A.A. Formulation and biological evaluation of glimepiride-cyclodextrinpolymer systems. Int. J. Pharm., 2006, 309, 129-138.
-
(2006)
Int. J. Pharm
, vol.309
, pp. 129-138
-
-
Ammar, H.O.1
Salama, H.A.2
Ghorab, M.3
Mahmoud, A.A.4
-
71
-
-
35248822616
-
The utility of cyclodextrins for enhancing oral bioavailability
-
Carrier, R.L.; Miller L.A.; Ahmed, I. The utility of cyclodextrins for enhancing oral bioavailability. J. Control. Release, 2007, 123, 78-99.
-
(2007)
J. Control. Release
, vol.123
, pp. 78-99
-
-
Carrier, R.L.1
Miller, L.A.2
Ahmed, I.3
-
72
-
-
76749145973
-
Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with betacyclodextrin and hydroxypropyl-betacyclodextrin
-
Ranpise, N.S.; Kulkarni, N.S.; Mair, P.D.; Ranade, A.N. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with betacyclodextrin and hydroxypropyl-betacyclodextrin. Pharm. Dev. Technol., 2010, 15, 64-70.
-
(2010)
Pharm. Dev. Technol
, vol.15
, pp. 64-70
-
-
Ranpise, N.S.1
Kulkarni, N.S.2
Mair, P.D.3
Ranade, A.N.4
-
73
-
-
59049099567
-
Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques
-
Al-Marzouqi, A.H.; Elwy, H.M.; Shehadi, I.; Adem, A. Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J. Pharm. Biomed. Anal., 2009, 49, 227-233.
-
(2009)
J. Pharm. Biomed. Anal
, vol.49
, pp. 227-233
-
-
Al-Marzouqi, A.H.1
Elwy, H.M.2
Shehadi, I.3
Adem, A.4
-
74
-
-
0032885450
-
Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs
-
Serajuddin, A.T.M. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci., 1999, 88, 1058-1066.
-
(1999)
J. Pharm. Sci
, vol.88
, pp. 1058-1066
-
-
Serajuddin, A.T.M.1
-
75
-
-
26444493103
-
Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder
-
Wang, L.A.; Cui, F.D.; Hayase, T.; Sunada, H. Preparation and evaluation of solid dispersion for nitrendipine-carbopol and nitrendipine-HPMCP systems using a twin screw extruder. Chem. Pharm. Bull., 2005, 53, 1240-1245.
-
(2005)
Chem. Pharm. Bull
, vol.53
, pp. 1240-1245
-
-
Wang, L.A.1
Cui, F.D.2
Hayase, T.3
Sunada, H.4
-
76
-
-
29844438761
-
Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method
-
Wang, L.; Cui, F.D.; Sunada, H. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method. Chem. Pharm. Bull., 2006, 54, 37-43.
-
Chem. Pharm. Bull
, vol.54
, pp. 37-43
-
-
Wang, L.1
Cui, F.D.2
Sunada, H.3
-
77
-
-
34548240849
-
Solid dispersion of Spironolactone with porous silica prepared by the solvent method
-
Uchino, T.; Yasuno, N.; Yanagihara, Y.; Suzuki, H. Solid dispersion of Spironolactone with porous silica prepared by the solvent method. Pharmazie, 2007, 62, 599-603.
-
(2007)
Pharmazie
, vol.62
, pp. 599-603
-
-
Uchino, T.1
Yasuno, N.2
Yanagihara, Y.3
Suzuki, H.4
-
78
-
-
39149138682
-
Particle design of poorly water soluble drug substances using supercritical fluid technologies
-
Yasuji, T.; Takeuchi, H.; Kawashima, Y. Particle design of poorly water soluble drug substances using supercritical fluid technologies. Adv. Drug Deliv. Rev., 2008, 60, 388-398.
-
(2008)
Adv. Drug Deliv. Rev
, vol.60
, pp. 388-398
-
-
Yasuji, T.1
Takeuchi, H.2
Kawashima, Y.3
-
79
-
-
84862767896
-
Solution for poorly water-soluble drugs
-
Fuji chemical industries Co. Ltd, Last accessed October 6, 2010
-
Solution for poorly water-soluble drugs. Fuji chemical industries Co. Ltd., www.fujichemical.co.jp/english (Last accessed October 6, 2010).
-
-
-
-
80
-
-
72049110480
-
Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: Chitosan-Oisopropyl-5'-O-d4T monophosphate conjugate
-
Yang, L.; Chen, L.; Zeng, R.; Li, C.; Qiao, R.; Hu, L.; Li, Z. Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: Chitosan-Oisopropyl-5'-O-d4T monophosphate conjugate. Bioorg. Med. Chem., 2010, 18, 117-123.
-
(2010)
Bioorg. Med. Chem
, vol.18
, pp. 117-123
-
-
Yang, L.1
Chen, L.2
Zeng, R.3
Li, C.4
Qiao, R.5
Hu, L.6
Li, Z.7
-
81
-
-
84862764854
-
-
Acusphere's Hydrophobic Drug Delivery Systems (HDDS™) Technology Receives Additional Validation, Nanoscience and technology institute. [Last accessed 19 October, 2010]
-
Acusphere's Hydrophobic Drug Delivery Systems (HDDS™) Technology Receives Additional Validation. http://www.nsti.org/press/PRshow.html?id=617. Nanoscience and technology institute. [Last accessed 19 October, 2010].
-
-
-
-
82
-
-
84862765370
-
Meeting the challenges of poorly soluble drug compounds
-
Eurand, [Last accessed 15 October, 2010]
-
Meeting the challenges of poorly soluble drug compounds. Eurand www.eurand.com. [Last accessed 15 October, 2010].
-
-
-
-
83
-
-
84862756259
-
Solubility and bioavailability enhancers
-
[Last accessed 19 October, 2010]
-
Solubility and bioavailability enhancers. http://www.gattefosse.com/internet/gatt-wk3.nsf/TECHDOCPARCLEF/00000309?OpenDocument&Menu=1. [Last accessed 19 October, 2010].
-
-
-
-
84
-
-
75649095989
-
Bioavailability enhancing activities of natural compounds from medicinal plants
-
Kang, M.J.; Cho, J.Y.; Shim, B.H.; Kim, D.K.; Lee, J. Bioavailability enhancing activities of natural compounds from medicinal plants. J. Med. Plants Res., 2009, 3 (13), 1204-1211.
-
(2009)
J. Med. Plants Res
, vol.3
, Issue.13
, pp. 1204-1211
-
-
Kang, M.J.1
Cho, J.Y.2
Shim, B.H.3
Kim, D.K.4
Lee, J.5
-
85
-
-
0003455057
-
Guidance to industry: Waiver of in vivo BA and BE studies for immediate release solid oral dosage forms based on a biopharmaceutical classification system
-
FDA Guidance
-
FDA Guidance, 2000. Guidance to industry: Waiver of in vivo BA and BE studies for immediate release solid oral dosage forms based on a biopharmaceutical classification system.
-
(2000)
-
-
-
86
-
-
1842450785
-
A dynamic artificial gastrointestinal system for studying the behaviour of orally administered drug dosage forms under various physiological conditions
-
Blanquet, S.; Zeijdner, E.; Beyssac, E.; Meunier, J.P.; Denis, S.; Havenaar, R.; Alric, M. A dynamic artificial gastrointestinal system for studying the behaviour of orally administered drug dosage forms under various physiological conditions. Pharm. Res., 2004, 21 (4), 585-591.
-
(2004)
Pharm. Res
, vol.21
, Issue.4
, pp. 585-591
-
-
Blanquet, S.1
Zeijdner, E.2
Beyssac, E.3
Meunier, J.P.4
Denis, S.5
Havenaar, R.6
Alric, M.7
-
87
-
-
56049112383
-
Applications of physiologically based absorption models in drug discovery and development
-
Parrott, N.; Lave, T. Applications of physiologically based absorption models in drug discovery and development. Mol. Pharm., 2008, 5 (5), 760-775.
-
(2008)
Mol. Pharm
, vol.5
, Issue.5
, pp. 760-775
-
-
Parrott, N.1
Lave, T.2
-
88
-
-
32344446760
-
Role of Caco-2 cell monolayers in prediction of intestinal drug absorption
-
Shah, P.; Jogani, V.; Bagchi, T.; Misra, A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol. Prog., 2006, 22 (1), 186-198.
-
(2006)
Biotechnol. Prog
, vol.22
, Issue.1
, pp. 186-198
-
-
Shah, P.1
Jogani, V.2
Bagchi, T.3
Misra, A.4
-
90
-
-
2642527944
-
Combined applications of parallel artificial membrane permeability assay and CaCo-2 permeability assays in drug discovery
-
Kerns, E.H.; Di, L.; Petusky, S.; Farris, M.; Ley, R.; Jupp, P. Combined applications of parallel artificial membrane permeability assay and CaCo-2 permeability assays in drug discovery. J. Pharm. Sci., 2004, 93 (6), 1440-1453.
-
(2004)
J. Pharm. Sci
, vol.93
, Issue.6
, pp. 1440-1453
-
-
Kerns, E.H.1
Di, L.2
Petusky, S.3
Farris, M.4
Ley, R.5
Jupp, P.6
-
91
-
-
0029058745
-
IAM chromatography: An in vitro screen for predicting drug membrane permeability
-
Pidgeon, C.; Ong, S.; Liu, H.; Qiu, X.; Pidgeon, M.; Dantzig, A.H.; Munroe, J.; Hornback, W.J.; Kasher, J.S.; Glunz, L. IAM chromatography: an in vitro screen for predicting drug membrane permeability. J. Med. Chem., 1995, 38, 590-594.
-
(1995)
J. Med. Chem
, vol.38
, pp. 590-594
-
-
Pidgeon, C.1
Ong, S.2
Liu, H.3
Qiu, X.4
Pidgeon, M.5
Dantzig, A.H.6
Munroe, J.7
Hornback, W.J.8
Kasher, J.S.9
Glunz, L.10
-
92
-
-
0027473738
-
Estimating the fraction dose absorbed from suspensions of poorly soluble substances in humans: A mathematical model
-
Oh D.M.; Curl, R.L.; Amidon, G.L.; Estimating the fraction dose absorbed from suspensions of poorly soluble substances in humans: a mathematical model. Pharm. Res., 1993, 10 (2), 264-270.
-
(1993)
Pharm. Res
, vol.10
, Issue.2
, pp. 264-270
-
-
Oh, D.M.1
Curl, R.L.2
Amidon, G.L.3
-
93
-
-
0033427120
-
An integrated model for determining causes of poor oral drug absorption
-
Yu, L.X. An integrated model for determining causes of poor oral drug absorption. Pharm. Res., 1999, 16 (12), 1883-1888.
-
(1999)
Pharm. Res
, vol.16
, Issue.12
, pp. 1883-1888
-
-
Yu, L.X.1
-
94
-
-
80054075223
-
-
AAPS Annual Meeting, Baltimore, MA
-
Collins, D and Rose, J. Lead Profiling: Biopharmaceutical Molecular Platform Classification. AAPS Annual Meeting, Baltimore, MA, 2004, p. 38.
-
(2004)
Lead Profiling: Biopharmaceutical Molecular Platform Classification
, pp. 38
-
-
Collins, D.1
Rose, J.2
-
95
-
-
0030444550
-
Guidance in the setting of drug particle size specifications to minimize variability in absorption
-
Johnson, K.C.; Swindell, A.C. Guidance in the setting of drug particle size specifications to minimize variability in absorption. Pharm. Res., 1996, 13, 1795-1798.
-
(1996)
Pharm. Res
, vol.13
, pp. 1795-1798
-
-
Johnson, K.C.1
Swindell, A.C.2
-
96
-
-
0035478779
-
Predicting the impact of physiological and biochemical processes on oral drug bioavailability
-
Agoram, B.; Woltosz, W.S.; Bolger, M.B. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv. Drug Del. Rev., 2001, 50, S41-S61.
-
(2001)
Adv. Drug Del. Rev
, vol.50
-
-
Agoram, B.1
Woltosz, W.S.2
Bolger, M.B.3
-
97
-
-
80054078979
-
Enhancement & controlled release as synergistic tools
-
Bryan, W.J. Enhancement & controlled release as synergistic tools. Drug Deliv. Technol., 2002, 2 (6).
-
(2002)
Drug Deliv. Technol
, vol.2
, Issue.6
-
-
Bryan, W.J.1
-
98
-
-
0034960084
-
Magnetic marker monitoring of disintegrating capsules
-
Weitschies, W.; Karaus, M.; Cordini, D.; Trahms, L.; Breitkreutz, J.; Semmler, W. Magnetic marker monitoring of disintegrating capsules. Eur. J. Pharm. Sci., 2001, 13, 411-416.
-
(2001)
Eur. J. Pharm. Sci
, vol.13
, pp. 411-416
-
-
Weitschies, W.1
Karaus, M.2
Cordini, D.3
Trahms, L.4
Breitkreutz, J.5
Semmler, W.6
-
99
-
-
33748361948
-
The use of accelerator mass spectrometry to obtain early human ADME/PK data
-
Lappin, G and Garner, R. The use of accelerator mass spectrometry to obtain early human ADME/PK data. Expert Opin. Drug Metabol. Toxicol. 2005, 1 (1), 23-31.
-
(2005)
Expert Opin. Drug Metabol. Toxicol
, vol.1
, Issue.1
, pp. 23-31
-
-
Lappin, G.1
Garner, R.2
-
100
-
-
0026465629
-
Gamma scintigraphy in the evaluation of pharmaceutical dosage forms
-
Davis, S.S.; Hardy, J.G.; Newman, S.P.; Wilding, I.R. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med., 1992, 19 (11), 971-986.
-
(1992)
Eur. J. Nucl. Med
, vol.19
, Issue.11
, pp. 971-986
-
-
Davis, S.S.1
Hardy, J.G.2
Newman, S.P.3
Wilding, I.R.4
|